[HTML][HTML] Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?
AA Abdo, FM Sanai, FZ Al-Faleh - Saudi Journal of …, 2012 - journals.lww.com
Some 400 million people worldwide are currently infected with the hepatitis B virus (HBV),
and the infection is common in the Middle East. Another 170 million people around the globe …
and the infection is common in the Middle East. Another 170 million people around the globe …
[HTML][HTML] Management of hepatitis C virus genotype 4: recommendations of an international expert panel
…, MP Manns, PL Almasio, R Esteban, AA Abdo… - Journal of …, 2011 - Elsevier
HCV has been classified into no fewer than six major genotypes and a series of subtypes.
Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution…
Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution…
Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome
AA Abdo, VG Bain, K Kichian, SS Lee - Hepatology, 2002 - journals.lww.com
Recently, the autoimmune hepatitis (AIH)/primary sclerosing cholangitis (PSC) overlap syndrome
has been reported increasingly. In this syndrome, patients present with features of both …
has been reported increasingly. In this syndrome, patients present with features of both …
[HTML][HTML] Six minute walk test to assess functional capacity in chronic liver disease patients
…, KA Al-Swat, AS Hersi, AA Abdo - World journal of …, 2007 - ncbi.nlm.nih.gov
AIM: To examine the utility of Six Minute Walk Test (6MWT) in patients with chronic liver
disease (CLD). METHODS: Two hundred and fifty subjects between the ages of 18 and 80 (…
disease (CLD). METHODS: Two hundred and fifty subjects between the ages of 18 and 80 (…
Long-term protection of hepatitis B vaccine 18 years after vaccination
…, S AlAnsari, M AlJeffri, Y AlMazrou, A Shaffi, AA Abdo - Journal of infection, 2008 - Elsevier
INTRODUCTION: This is the third evaluation study of the hepatitis B virus (HBV) vaccination
program, initiated in 1989 in Saudi Arabia. AIMS: This study sought to assess the efficacy …
program, initiated in 1989 in Saudi Arabia. AIMS: This study sought to assess the efficacy …
The coagulopathy of liver disease: does vitamin K help?
Vitamin K is frequently administered in cirrhotic patients to correct their coagulopathy, but
evidence for such practice is lacking. We aimed to assess whether vitamin K administration …
evidence for such practice is lacking. We aimed to assess whether vitamin K administration …
[HTML][HTML] Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia
AA Abdo, BM Al-Jarallah, FM Sanai… - World Journal of …, 2006 - ncbi.nlm.nih.gov
AIM: To identify the most common hepatitis B virus (HBV) genotype in Saudi Arabia, and
correlate the prevailing genotypes with the clinical outcome of patients. METHODS: Patients …
correlate the prevailing genotypes with the clinical outcome of patients. METHODS: Patients …
[HTML][HTML] Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients
AA Al-Qahtani, MR Al-Anazi, AA Abdo, FM Sanai… - Plos one, 2014 - journals.plos.org
Hepatitis B virus (HBV) infection is a leading cause of liver diseases including cirrhosis and
hepatocellular carcinoma. Human leukocyte antigens (HLAs) play an important role in the …
hepatocellular carcinoma. Human leukocyte antigens (HLAs) play an important role in the …
[HTML][HTML] Use of alternative medicine by Saudi liver disease patients attending a tertiary care center: prevalence and attitudes
…, SA Al-Sofayan, HA Abunab, AA Abdo - Saudi Journal of …, 2013 - journals.lww.com
Materials and Methods: Patients were recruited randomly from a tertiary care hepatology
clinic at King Khalid University Hospital (KKUH), Riyadh, Saudi Arabia from February 4 to …
clinic at King Khalid University Hospital (KKUH), Riyadh, Saudi Arabia from February 4 to …
[HTML][HTML] Correlation between hepatitis B surface antigen titers and HBV DNA levels
Results: The median (range) log10 HBsAg titer was significantly lower in the IC group
compared with AH group, 3.09 (− 1 to–4.4) versus 3.68 (− 0.77 to 5.09) IU/mL, respectively; P< …
compared with AH group, 3.09 (− 1 to–4.4) versus 3.68 (− 0.77 to 5.09) IU/mL, respectively; P< …